TLDR: "Discontinuation of GLP-1RA treatment leads to weight regain, regardless of lifestyle interventions, and should therefore be considered a chronic therapy to prevent weight regain and associated undesirable outcomes related to obesity." Key findings: After stopping liraglutide, patients regained ~2.2 kg After stopping semaglutide/tirzepatide, patients regained ~9.7 kg Weight regain was proportional to initial weight loss Lifestyle changes alone DID NOT prevent regain Implication: GLP-1 receptor agonists are not a short-term solution
It is critical that employers, health plans, and providers provide people with a solution that includes support for behavior change and mental health needs either complementary to the drug or instead of it
Suitable for both men & women
Consume 2030 minutes before performance
How Muscle Loss Impacts Your Health: GLP-1 Drugs Muscle loss from GLP-1 drugs negatively impacts: Cardiovascular health Metabolic health Physical function Given the importance of muscle mass on your health and physical function, its important to find and incorporate into your lifestyle, factors that prevent muscle loss during GLP-1 medication use